MYC and neoplasm: However, the mouse cohorts treated with bacteria expressing shRNA targeting c-Myc had greatly extended survival times compared to the scrambled shRNA treatment cohort, with variance attributable to large differences in tumour burden between individual mice at the time of treatment.